Intrommune Therapeutics, Inc. is a biotechnology company located in New York, NY. Intrommune is developing food allergy immunotherapies that are delivered while you brush your teeth, a lifelong habit that is ingrained in most people and ensures daily use of our product. Intrommune's elegant new treatment platform for food allergies is expected to be safe, effective and convenient. Intrommune’s first product is a therapy for patients who suffer from peanut allergy.
Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 32 million people in the U.S., who suffer from this life-altering condition.
Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 32 million people in the U.S., who suffer from this life-altering condition.
Location: United States, New York
Employees: 11-50
Phone: +1 844-664-8669
Founded date: 2015
Investors 2
| Date | Name | Website |
| 09.07.2021 | Robin Hood... | robinhoodv... |
| - | Red Bear A... | rbangels.c... |
Mentions in press and media 2
| Date | Title | Description |
| 12.03.2024 | Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya | - |
| 21.06.2021 | Unicorn Hunters S1 EP4: Intrommune | June 21, 2021 1 min read Opinions expressed by Entrepreneur contributors are their own. More than half a billion people live with food-related allergies around the world, and Intrommune Therapeutics aims to help them live without fear by tr... |